Natalie C. Holles Third Harmonic Bio, Inc. (THRD) insider trading activity

THRD Quotes by TradingView

Natalie C. Holles is CEO of Third Harmonic Bio, Inc.. Currently has a direct ownership of 1.22 Million shares of THRD, which is worth approximately $16.8 Million. The most recent transaction as insider was on May 09, 2024, when has been sold 20,222 shares (Common Stock) at a price of $12.18 per share, resulting in proceeds of $246,303. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.22M
0% 3M change
n/a 12M change
Total Value Held $16.8 Million

Natalie C. Holles Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 09 2024
SELL
Open market or private sale
$246,303 $12.18 p/Share
20,222 Reduced 1.63%
1,218,836 Common Stock
May 09 2024
BUY
Exercise of conversion of derivative security
$84,932 $4.2 p/Share
20,222 Added 1.61%
1,239,058 Common Stock
Apr 11 2024
SELL
Open market or private sale
$165,272 $12.19 p/Share
13,558 Reduced 1.1%
1,218,836 Common Stock
Apr 11 2024
BUY
Exercise of conversion of derivative security
$56,943 $4.2 p/Share
13,558 Added 1.09%
1,232,394 Common Stock

Also insider at

ALLK
Allakos Inc. Healthcare
Director
RUBY
Rubius Therapeutics, Inc. Healthcare
Director
DAWN
Day One Biopharmaceuticals, Inc. Healthcare
NCH

Natalie C. Holles

CEO
South San Francisco, CA

Track Institutional and Insider Activities on THRD

Follow Third Harmonic Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRD shares.

Notify only if

Insider Trading

Get notified when an Third Harmonic Bio, Inc. insider buys or sells THRD shares.

Notify only if

News

Receive news related to Third Harmonic Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on THRD